The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fat‐Soluble Vitamin Status and Supplementation in a Pediatric Cystic Fibrosis Cohort
Pediatric Pulmonology · 2026-04 · 61 (4)
DOI: 10.1002/ppul.71596 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 03.04.2026. Verfasst von Fern Kimber und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Queen's Medical Centre, University of Nottingham, Nottingham, UK. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pyrrolidines, Indoles, Quinolones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Children with Cystic Fibrosis (CF) are at risk of fat‐soluble vitamin deficiencies, studies have shown Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy to substantially improve nutritional status. This study aimed to investigate the effect of ETI on fat‐soluble vitamin levels A, D, and E, for children aged 6–16 years with CF.
Method
We performed a retrospective pre‐post study of children with CF. Data collected included demographics, clinical characteristics, serum Vitamin A, D and E and vitamin supplementation dosages. Seven timepoints were decided for statistical analysis: T1–T3—pre‐ETI and T4–T7—at 6 month intervals post‐ETI. The significance of changes in vitamin levels and supplementation was assessed using a linear mixed‐effects model. A p ‐value < 0.05 was used to indicate significance.
Results
Fifty‐six children met the inclusion criteria, with 262, 257, and 252 complete observations for Vitamins A, D, and E, respectively. Median Vitamin D levels increased following ETI initiation ( p < 0.001). There was no significant increase in median Vitamin A levels however post‐ETI there was a significant association between supplementation dose and serum Vitamin A levels ( p = 0.008). There were no significant changes in median Vitamin E. Over the timepoints there was an increase in the proportion of patients receiving no vitamin supplementation.
Conclusions
This study found following ETI initiation vitamin D levels increased, and the requirement for fat‐soluble vitamin supplementation appeared to decrease. Whilst ETI was not associated with increased Vitamin A and E, the burden of supplementation decreased, and Vitamin A supplementation maybe more effective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Queen's Medical Centre, University of Nottingham, Nottingham, UK.
- Nutrition and Dietetics, Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, UK.
- NIHR Nottingham Biomedical Research Centre, Queen's Medical Centre, University of Nottingham, Nottingham, UK.
ORCID-Profile: Fern Kimber, Darren Sills
Zitieren
APA
Kimber, F., & Sills, D. (2026). The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fat‐Soluble Vitamin Status and Supplementation in a Pediatric Cystic Fibrosis Cohort. Pediatric Pulmonology, 61(4). https://doi.org/10.1002/ppul.71596
Vancouver
Kimber F, Sills D. The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fat‐Soluble Vitamin Status and Supplementation in a Pediatric Cystic Fibrosis Cohort. Pediatric Pulmonology. 2026;61(4). doi:10.1002/ppul.71596
BibTeX
@article{Kimber2026,
author = {Kimber, Fern and Sills, Darren},
title = {The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fat‐Soluble Vitamin Status and Supplementation in a Pediatric Cystic Fibrosis Cohort},
journal = {Pediatric Pulmonology},
year = {2026},
volume = {61},
number = {4},
doi = {10.1002/ppul.71596}
}
EUVIMED